Generated net FUROSCIX® revenue of $16 million in the second quarter of 2025; up 99% over Q2 2024
scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update
Seeking Alpha / 1 hour ago 1 Views
Seeking Alpha / 1 hour ago 1 Views
Generated net FUROSCIX® revenue of $16 million in the second quarter of 2025; up 99% over Q2 2024
Comments